 Arix Bioscience PLC LON:ARIX has issued a response to an open letter from activist shareholder Acacia Research Corporation released on Monday. The biotech-focused venture capital firm said it was disappointed that Acacia had decided to publish the letter on the same date as delivering it to the company, adding that it has an experienced board that is committed to acting in the best interest of all shareholders. 